Evidence map›Paper›PMID 36626253›Full record

ArticleAging2023

Genetic deficiency and pharmacological modulation of RORα regulate laser-induced choroidal neovascularization.

Chi-Hsiu Liu, Felix Yemanyi, Kiran Bora, Neetu Kushwah, Alexandra K Blomfield, Theodore M Kamenecka, John Paul SanGiovanni, Ye Sun, Laura A Solt, Jing Chen

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Chi-Hsiu LiuDepartment of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Felix YemanyiDepartment of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Kiran BoraDepartment of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Neetu KushwahDepartment of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Alexandra K BlomfieldDepartment of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Theodore M KameneckaDepartment of Molecular Medicine, UF Scripps Biomedical Research, Jupiter, FL 33458, USA.
John Paul SanGiovanniBIO5 Institute and Department of Nutritional Sciences, University of Arizona, Tucson, AZ 85719, USA.
Ye SunDepartment of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Laura A SoltDepartment of Molecular Medicine, UF Scripps Biomedical Research, Jupiter, FL 33458, USA.
Jing ChenDepartment of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Harvard University · USBoston Children's Hospital · USScripps (United States) · USThe Herbert Wertheim UF Scripps Institute for Biomedical Innovation & TechnologyUniversity of Arizona · US

Funding

RORalpha mediates chronic subretinal inflammation associated with AMDR01EY024963 · NEI · BOSTON CHILDREN'S HOSPITAL · PI CHEN, JING · 2015 to 2025
$4.2M
Regulation of RPE degeneration by REV-ERBalphaR01EY031765 · NEI · BOSTON CHILDREN'S HOSPITAL · PI JING CHEN · 2020 to 2026
$2.7M
Photoreceptor Determination of Retinal Blood Vessel Growth in RetinopathyR01EY029238 · NEI · BOSTON CHILDREN'S HOSPITAL · PI YE SUN · 2019 to 2026
$2.6M
Wnt signaling-mediated control of blood-retinal barrierR01EY028100 · NEI · BOSTON CHILDREN'S HOSPITAL · PI CHEN, JING · 2017 to 2021
$2.2M
The Mechanism of Immune-Vascular Crosstalk in RetinopathyR01EY030140 · NEI · BOSTON CHILDREN'S HOSPITAL · PI SUN, YE · 2019 to 2023
$2.0M
NEI NIH HHS R01 EY024963NEI NIH HHS R01 EY028100NEI NIH HHS R01 EY029238NEI NIH HHS R01 EY030140NEI NIH HHS R01 EY031765
6 · The paper itself

Abstract

Choroidal neovascularization (CNV) causes acute vision loss in neovascular age-related macular degeneration (AMD). Genetic variations of the nuclear receptor RAR-related orphan receptor alpha (RORα) have been linked with neovascular AMD, yet its specific role in pathological CNV development is not entirely clear. In this study, we showed that

Indexed as

Choroidal NeovascularizationWet Macular DegenerationAngiogenesis InhibitorsAnimalsDisease Models, AnimalHumansLasersMiceMice, Inbred C57BLVascular Endothelial Growth Factor AVisual AcuityAngiogenesis InhibitorsVascular Endothelial Growth Factor Aage-related macular degenerationangiogenesischoroidal neovascularizationinflammationnuclear receptorsRORαTNFαVEGFR2

Identifiers

PMID36626253
PMCPMC9876633
OpenAlexW4315436088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.